ReviewEuropean journal of pediatrics2026
Hepatic manifestations of ciliopathies: genetic causes and clinical update.
Review in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ciliopathies are genetically heterogeneous disorders of primary cilia that frequently involve the liver in childhood, producing a spectrum of hepatobiliary pathology. Primary cilia on cholangiocytes and hepatic progenitors are mechano-, chemo-, and osmo-sensors essential for remodelling of the ductal plate, the embryologic precursor of the liver's intrahepatic bile duct system. Disruption of the components of primary cilia (basal body, intraflagellar transport (IFT), transition-zone, trafficking, and endoplasmic reticulum (ER)/Golgi protein homeostasis components) leads to ductal plate malformation, aberrant biliary branching, and progressive periductal fibrosis. Classical loci (PKHD1, PKD1, PKD2) more commonly associated with cystic kidney disease remain central to aetiology, while ER/glycosylation protein homeostasis genes (GANAB, ALG8, PRKCSH, SEC63, DNAJB11), trafficking/IFT-A and WDR/dynein-2 components (TULP3, WDR family) are increasingly recognised. Liver disease most often appears from childhood to adolescence in autosomal recessive polycystic kidney disease (ARPKD), Bardet-Biedl syndrome, Joubert syndrome, and WDR-related disorders, while autosomal dominant polycystic kidney and liver disease (ADPKD and ADPLD) usually presents in adulthood. The main disease patterns also vary: congenital hepatic fibrosis and portal hypertension in ARPKD, hepatic cysts in ADPKD, steatotic liver disease in Bardet-Biedl syndrome, and transaminitis or fibrocystic liver disease in Joubert and WDR-related disorders. Emerging contributors such as DCDC2 and PKD1L1 implicate microtubule-cilium interactions and mechanosensory dysfunction in neonatal cholestasis and biliary atresia. Diagnosis increasingly relies on broad multigene panels or exome/genome sequencing, with functional assays guiding interpretation of novel alleles.
conclusionThis narrative review synthesises contemporary knowledge on ciliary roles in biliary development, the clinical hepatic phenotypes observed in children and adults, and the evolving genetic landscape with emphasis on discoveries from recent sequencing cohorts and functional studies. WHAT IS KNOWN: • Ciliopathies are genetically heterogeneous disorders in which primary cilia dysfunction disrupts cholangiocyte signalling and ductal plate remodelling, leading to a spectrum of paediatric hepatobiliary disease ranging from congenital hepatic fibrosis and portal hypertension to cystic liver disease, steatotic liver disease, and neonatal cholestasis. WHAT IS NEW: • Recent genomic and functional studies have broadened the spectrum of ciliopathy-associated genes implicated in paediatric hepatic disease. Clinicians caring for these children should maintain a high index of suspicion as the range of reported phenotypes continues to expand.
Indexed as
Identifiers
42855640What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.